For two years, 60 Minutes has followed the clinical trials at Duke University where a modified version of the polio virus is being used to eliminate brain cancer tumors called Glioblastoma. The FDA had previously approved the trial in humans in 2011, and has recently granted the treatment “breakthrough status” which means that the clinical trials can move more quickly than usual. The second phase of the trial will be expanded to about 40 institutions.
WB | Clinical has been providing a wide range of operational and ongoing compliance services at Duke University to ensure trials like this can go uninterrupted and smoothly as possible.
Click here to watch the 60 Minutes report.